Imaging News and Research

RSS

Study unveils surprising mechanism that controls brain formation

A study from The Scripps Research Institute has unveiled a surprising mechanism that controls brain formation. The findings have implications for understanding a host of diseases, including some forms of mental retardation, epilepsy, schizophrenia, and autism.

10 Feb 2011

Scientists discover KCNH2 gene mutation in patients with long QT syndrome

Researchers from the Hospital Virgen de las Nieves of the University of Granada have identified the most frequent mutations in the gene KCNH2 in patients with long QT syndrome.

10 Feb 2011

Mg significantly reduces neonatal brain injury linked with maternal inflammation, infection

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that showed that in rats, the use of magnesium sulfate significantly reduced the neonatal brain injury associated with maternal inflammation or maternal infection.

10 Feb 2011

Rcadia receives FDA 510(k) clearance for enhanced COR Analyzer System to assess coronary branch vessels

Rcadia Medical Imaging announced today that it has received FDA 510(k) marketing clearance for an enhanced version of its COR Analyzer® System to assess coronary branch vessels in addition to main coronary arteries in patients with suspected coronary artery disease (CAD).

10 Feb 2011

FDA clears EOS orthopedic imaging system for use in lower limbs applications

EOS imaging announced today that it has received FDA clearance of its sterEOS 3D orthopedic imaging workstation for use in lower limbs applications for patients 15 years and older.

9 Feb 2011

Mobily introduces first mobile medical imaging service

Saudi Arabian telecommunications company Mobily and Great Connection Inc., creator of the innovative Mobile Baby service, announced the launch of the first mobile medical imaging service that enables ultrasound stills, 3D images and video clips to be sent directly from an ultrasound machine to a mobile device.

9 Feb 2011

Clinical Data reports $2.0 million revenue for third quarter 2011

Clinical Data, Inc. today announced operational and financial results for the third fiscal quarter ended December 31, 2010. The Company received approval from the U.S. Food and Drug Administration (FDA) of Viibryd™ for the treatment of adults with major depressive disorder (MDD) on January 21, 2011.

9 Feb 2011

Repligen third quarter total revenue increases 26% to $7,068,000

Repligen Corporation today reported results for the third quarter of fiscal year 2011, ended December 31, 2010. Total revenue for the quarter was $7,068,000 compared to total revenue of $5,617,000 for the third quarter of fiscal year 2010 ended December 31, 2009, an increase of $1,451,000 or 26%.

9 Feb 2011

Single molecule imaging movies of living cell membranes clarify enigma surrounding receptor molecule behaviors

Unprecedented single molecule imaging movies of living cell membranes, taken by a research team based at Kyoto University and the University of New Mexico, have clarified a decades-old enigma surrounding receptor molecule behaviors. The results, appearing in the latest issue of the Journal of Cell Biology, promise to open the door to new possibilities for drug development.

9 Feb 2011

New research provides evidence that cerebellum can also store memories for mental skills

Movements become skilled and automatic with practise, so tasks like riding a bicycle can be performed without much attention or mental effort. New research by scientists at Royal Holloway, University of London provides evidence that the cerebellum, a part of the brain used to store memories for skilled movements, could also store memories important for mental skills - such as the rules used to interpret traffic light signals.

9 Feb 2011

Specific gene variation linked to late-onset Alzheimer's

A new study from the Centre for Addiction and Mental Health (CAMH) has found evidence suggesting that a variation of a specific gene may play a role in late-onset Alzheimer's, the disease which accounts for over 90% of Alzheimer's cases. This innovative study has combined genetics and brain imaging to determine who may be at risk for developing late-onset Alzheimer's disease long before symptoms appear.

9 Feb 2011

Researchers link brain's neural networks to specific cognitive functions

The human brain operates as a highly interconnected small-world network, not as a collection of discrete regions as previously believed, with important implications for why many of us experience cognitive declines in old age, a new study shows.

9 Feb 2011

Specific gene variation may play a role in late-onset Alzheimer's disease: New study

A new study from the Centre for Addiction and Mental Health has found evidence suggesting that a variation of a specific gene may play a role in late-onset Alzheimer's, the disease which accounts for over 90% of Alzheimer's cases. This innovative study has combined genetics and brain imaging to determine who may be at risk for developing late-onset Alzheimer's disease long before symptoms appear.

9 Feb 2011

Revo pacemaker receives FDA approval for use during certain MRI exams

The U.S. Food and Drug Administration today approved the first heart pacemaker designed to be used safely during certain magnetic resonance imaging (MRI) exams.

9 Feb 2011

DE-MRI holds promise for predicting risks of strokes

Researchers at the University of Utah's Comprehensive Arrhythmia and Research Management Center have found that delayed-enhancement magnetic resonance imaging holds promise for predicting the risks of strokes, the third leading cause of death in the U.S.

9 Feb 2011

Positron anticipates expanded market opportunity for Attrius PET scanner

Positron Corporation a molecular imaging solutions company focused on nuclear cardiology, announced today that with the conditional U.S. Food and Drug Administration (FDA) approval of Eli Lilly's PET imaging agent Amyvid (florbetapir), it expects to see an expanded market opportunity for its Attrius® PET scanner.

8 Feb 2011

FDA approves Medtronic's new Revo MRI pacemaker

Medtronic, today announced that the U.S. Food and Drug Administration approved its Revo MRI SureScan pacing system, the first and only pacemaker in the U.S. specifically designed for use in an Magnetic Resonance Imaging environment and approved as MR-Conditional. Shipments of Revo MRI will begin immediately.

8 Feb 2011

RemedyMD announces new ComprehensiveBMT to solve key HSCT research challenges

RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.

8 Feb 2011

New facilities for developing imaging tests in PESA CNIC-Santander study inaugurated

Felipe P-triz, Secretary of State for Research and Emilio Bot-n, president of Banco Santander have inaugurated today in Banco Santander Finantial City (located in Boadilla del Monte) the new facilities for developing the first imaging tests included in PESA (Progression of Early Subclinical Atherosclerosis) CNIC-Santander study.

8 Feb 2011

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

Using a unique and relatively simple cell-based fluorescent assay they developed, scientists with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California, Berkeley have identified a means by which fluoxetine, the active ingredient in Prozac, suppresses the activity of the TREK1 potassium channel.

8 Feb 2011